Dossier
press
news report
TRT, GLP-1s, and peptides: How to counsel patients stacking longevity therapies
Key claim: Urology Times covers how clinicians should counsel patients stacking TRT, GLP-1 agonists, and peptides as longevity therapies.
Abstract
News coverage by Urology Times: “TRT, GLP-1s, and peptides: How to counsel patients stacking longevity therapies”. Headline and link only — this finding reports press coverage of a government action, not the primary record.
Why this matters
Urology Times covers how clinicians should counsel patients stacking TRT, GLP-1 agonists, and peptides as longevity therapies.